AMH
BNGO icon

Apollo Management Holdings’s Bionano Genomics BNGO Stock Holding History

Apollo Management Holdings’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39
Closed -$190K – 118
2021
Q1 		$190K Buy
+39
New +$220K ﹤0.01% 144

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Apollo Management Holdings's BNGO Position: Q2 2021 in Review

Apollo Management Holdings sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 39 shares — an estimated $190K sold.

Apollo Management Holdings first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $190K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

  • Apollo Management Holdings reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
  • Apollo Management Holdings sold 39 Bionano Genomics shares in Q2 2021, an estimated $190K.
  • Apollo Management Holdings first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
  • Apollo Management Holdings's Bionano Genomics position peaked at $190K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Apollo Management Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.